Lemercier Jean-Luc M 4

4 · Edwards Lifesciences Corp · Filed May 9, 2024

Form 4

Period: 2024-05-07

CVP, EMEA, Canada, Latin Amer

Transactions

Award
Common Stock
2024-05-07+7,125→ 184,834.806 total
Tax Payment
Common Stock
2024-05-07$85.09/sh−46$3,914→ 184,788.806 total
Award
Performance Rights
2024-05-07+7,125→ 7,125 total
From: 2027-05-07→ Common Stock (7,125 underlying)
Award
Employee Stock Option (Right to Acquire)
2024-05-07+42,200→ 42,200 total
Exercise: $85.84From: 2025-05-07Exp: 2031-05-06→ Common Stock (42,200 underlying)

Footnotes (3)

[F1]These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
[F2]These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments.
[F3]Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.

Documents

1 file